Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System.
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.
Test-retest reliability of four sensory measures in people with multiple sclerosis.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Relapse of neuromyelitis optica during pregnancy-Treatment options and literature review.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.
Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
A tissue-relaxation-dependent neighboring method for robust mapping of the myelin water fraction.
Modern communication technology skills of patients with multiple sclerosis.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Desirability and expectations of the UK MS Register: Views of people with MS.
The Subventricular Zone is Able to Respond to a Demyelinating Lesion after Localized Radiation.
Allopregnanolone: State of the art.
Imaging multiple sclerosis outside the brain.
[Cavitary lesions in multiple sclerosis: Multicenter study on twenty patients.]
Pages
« first
‹ previous
…
599
600
601
602
603
604
605
606
607
…
next ›
last »